June 22, 2015

PLEASANTON, Calif., June 22, 2015CooperVision, Inc. announced today that Simon Seshadri has been appointed Vice President, North America Marketing. In this role, Mr. Seshadri will be responsible for overseeing regional marketing strategies, including the development of product launches, ongoing programs, promotions, and demand creation initiatives.


Mr. Seshadri joined CooperVision in 2014 as Senior Director, Global Brand Marketing, for which he had global responsibility for the Biofinity® and Avaira® contact lens brands. Earlier this year, he took on additional responsibilities as the interim Vice President, North America Marketing.


“In his relatively brief time at CooperVision, Simon has already demonstrated a substantial impact on the organization in both his global and North America roles,” said Jerry Warner, President, North America, CooperVision. “Considering his more than 15 years of experience in healthcare marketing leadership roles, I’m confident that Simon will continue to drive successful marketing initiatives for our broad portfolio of contact lenses. His insights, initiative and ability to keep a finger on the pulse of the industry should generate success not only for CooperVision, but also deepen our partnerships with and growth of our customers’ practices.”


Prior to joining CooperVision, Mr. Seshadri served in a variety of national, regional and global marketing leadership roles with GE Healthcare, Bausch + Lomb, Philips Oral Healthcare, and Boots Healthcare. His previous responsibiliites have included the management of brand, professional, trade, and digital marketing teams in Japan, the United Kingdom, and the United States.


Mr. Seshadri holds a Bachelor of Commerce degree with a concentration in marketing from the University of British Columbia, and earned his master of business administration from the London Business School. He is based at CooperVision’s headquarters in Pleasanton, Calif.




About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses and related products and services. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.


About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has close to 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.


Media Contact

Heather Kowalczyk, McDougall Communications for CooperVision, Inc.

heather@mcdougallpr.com or 585-330-4878